Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 2 de 2
Filter
Add filters








Language
Year range
1.
Mem. Inst. Oswaldo Cruz ; 97(suppl.1): 85-90, Oct. 2002. ilus, tab, graf
Article in English | LILACS | ID: lil-325035

ABSTRACT

Schistosomes undergo various morphological and metabolic changes during their development, reflected in a finely tuned regulation of protein and/or gene expression. The mechanisms involved in the control of gene expression during the development of the parasite are not understood. Two actin genes had been previously cloned and observed to be differentially expressed during the maturation of the parasite. The SmAct gene contains four putative cis-regulatory elements (TATA-, CCAAT-, E- and CArG-boxes). Our objective was to investigate in greater detail the expression pattern of two actin genes and verify if the binding of nuclear proteins to the promoter elements of SmAct correlated with the expression profile observed. We detected little variation in the expression of actin genes during the first seven days of schistosomula culture in vitro. However, we observed significantly higher levels of expression in males compared to female adults. CArG and CCAAT elements bound to a greater extent and formed distinct complexes with male in comparison to female nuclear extracts. In contrast, female extracts bound weakly to the E-box probe while no binding was observed with male extracts. Taken together these results describe cis-acting elements that appear to be involved in sexually regulated gene expression in Schistosoma mansoni


Subject(s)
Animals , Male , Female , DNA-Binding Proteins , Gene Expression Regulation , Promoter Regions, Genetic , Schistosoma mansoni , Base Sequence , Blotting, Northern , CCAAT-Enhancer-Binding Proteins , Molecular Sequence Data , Nuclear Proteins , Regulatory Sequences, Nucleic Acid , Reverse Transcriptase Polymerase Chain Reaction , RNA, Messenger , Schistosoma mansoni , TATA-Box Binding Protein/analysis , Transcription Factors
2.
Braz. j. med. biol. res ; 31(1): 171-7, Jan. 1998.
Article in English | LILACS | ID: lil-212553

ABSTRACT

The role of diferent cytokines in the peripheral blood mononuclear cell (PBMC) proliferative response and in in vitro granuloma formation was evaluated in a cross-sectional study with patients with the different clinical forms and phases of Schistosoma mansoni infection, as well as a group of individuals "naturally" resistant to infection named normal endemic (NE). The blockage of IL-4 and IL-5 using anti-IL-4 and anti-IL-5 antibodies significantly reduced the PBMC proliferative response to soluble egg (SEA) and adult worm (SWAP) antigens in acute (ACT), chronic intestinal (INT) and hepatosplenic (HS) patients. Similar esults were obtained in the in vitro granuloma formation. Blockage of IL-10 had no significant effect on either assay using PBMC from ACT or HS. In contrast, the addition of anti-IL-10 antibodies to PBMC cultures from INT patients significantly increased the proliferative response to SEA and SWAP as well as the in vitro granuloma formation. Interestingly, association of anti-IL-4 and anti-IL-10 antibodies did not increase the PBMC proliferative response of these patients, suggesting that IL-10 may act by modulating IL-4 and IL-5 secretion. Addition of recombinant IL-10 decreased the proliferative response to undetectable levels when PBMC from patients with the different clinical forms were used. Analysis of IFN-gamma in the supernatants showed that PBMC from INT patients secreted low levels of IFN-gamma upon antigenic stimulation. In contrast, PBMC from NE secreted high levels of IFN-gamma. These data suggest that IL-10 is an important cytokine in regulating the immune response and possibly controlling morbidity in human schistosomiasis mansoni, and that the production of IFN-gamma may be associated with resistance to infection.


Subject(s)
Humans , Cytokines/physiology , Immunity, Innate/physiology , Schistosoma mansoni/pathogenicity , Schistosomiasis mansoni/immunology , Schistosomiasis mansoni/physiopathology , Interferon-gamma , Interleukin-10 , Interleukin-11 , Interleukin-4
SELECTION OF CITATIONS
SEARCH DETAIL